| scholarly article | Q13442814 |
| P50 | author | Rajesh Thakker | Q17502119 |
| P2093 | author name string | Angela Rogers | |
| P2860 | cites work | Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer | Q27851560 |
| A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns] | Q31942209 | ||
| Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer | Q33710562 | ||
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
| Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. | Q34989774 | ||
| Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. | Q36589374 | ||
| Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer | Q36822111 | ||
| Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study | Q36877022 | ||
| Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial | Q36910409 | ||
| Medullary thyroid cancer: management guidelines of the American Thyroid Association | Q37495961 | ||
| Genetics of congenital adrenal hyperplasia | Q37509474 | ||
| 46,XX DSD: the masculinised female | Q37764430 | ||
| Redefining disease | Q37854021 | ||
| Prenatal treatment of congenital adrenal hyperplasia-not standard of care | Q38013728 | ||
| Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. | Q42483973 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype | Q79988606 | ||
| Medullary thyroid cancer: options for systemic therapy of metastatic disease? | Q82892040 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 299-305 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Clinical Medicine | Q5133773 |
| P1476 | title | Clinically relevant genetic advances in endocrinology | |
| P478 | volume | 13 |
Search more.